- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ibio Inc (IBIO)
Ibio Inc stock price live, this page displays NASDAQ IBIO stock exchange data. View the IBIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ibio Inc real time stock price chart below.
What Is the Ibio Inc Stock Price Today?
The Ibio Inc stock price today is 0.5950.
What Is the Stock Symbol for Ibio Inc?
The stock symbol for Ibio Inc is ""IBIO.""
What Stock Exchange Does Ibio Inc Trade On?
Ibio Inc is listed and trades on the NASDAQ stock exchange.
Is Ibio Inc a Good Stock to Buy?
Determining whether Ibio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IBIO quote. (ISIN: US4510337086)
What Is the Ibio Inc Stock Price Today?
The Ibio Inc stock price today is 0.5950.
What Is the Stock Symbol for Ibio Inc?
The stock symbol for Ibio Inc is ""IBIO.""
What Stock Exchange Does Ibio Inc Trade On?
Ibio Inc is listed and trades on the NASDAQ stock exchange.
Is Ibio Inc a Good Stock to Buy?
Determining whether Ibio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IBIO quote. (ISIN: US4510337086)
NASDAQ
Currency in USD
0.5950
-0.0279(-4.48%)
Closed·
Pre Market
0.6099+0.0149(+2.50%)
·
Fair Value
An estimate of a Ibio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5900
0.6300
52 wk Range
0.5900
6.8908
IBIO Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Trading near 52-week Low
1/2
Fair Value
An estimate of a Ibio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.59000.6300
52 wk Range
0.59006.8908
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IBIO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ibio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
4.8667
Upside
+717.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Ibio Inc For: 1 August
- Investing.com
- Form 8K Ibio Inc For: 1 August
- Investing.com
- Form 8K Ibio Inc For: 24 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Ibio Inc Company Profile
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Compare IBIO to Peers and Sector
Metrics to compare | IBIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIBIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −3.7x | −0.5x | |
PEG Ratio | −0.01 | −0.19 | 0.00 | |
Price/Book | 0.8x | 2.4x | 2.6x | |
Price / LTM Sales | 25.7x | 11.4x | 3.3x | |
Upside (Analyst Target) | - | 118.9% | 43.5% | |
Fair Value Upside | Unlock | 1.2% | 6.9% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.8667
(+717.93% Upside)
Earnings
Latest Release
May 02, 2025
EPS / Forecast
-0.49 / -0.43
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Ibio Trade On?
Ibio is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Ibio?
The stock symbol for Ibio is "IBIO."
What Is the Ibio Market Cap?
As of today, Ibio market cap is 9.65M.
What Is Ibio's Earnings Per Share (TTM)?
The Ibio EPS (TTM) is -1.82.
From a Technical Analysis Perspective, Is IBIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ibio Stock Split?
Ibio has split 3 times.
How Many Employees Does Ibio Have?
Ibio has 16 employees.
What is the current trading status of Ibio (IBIO)?
As of 07 Aug 2025, Ibio (IBIO) is trading at a price of 0.60, with a previous close of 0.60. The stock has fluctuated within a day range of 0.59 to 0.63, while its 52-week range spans from 0.59 to 6.89.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.